Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
China Biotechs See Manufacturing Disruption As Cases Hit Suzhou
Shanghai Lockdown GDP Impact
Apr 14 2022
•
By
Brian Yang
CHINA BIOTECH CLUSTER SUZHOU REPORTS INCREASING COVID CASES, IMPOSES RESTRICTIONS • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia